4.5 Review

Emerging single-cell technologies in immunology

Journal

JOURNAL OF LEUKOCYTE BIOLOGY
Volume 98, Issue 1, Pages 23-32

Publisher

WILEY
DOI: 10.1189/jlb.6RU0115-020R

Keywords

sepsis; infectious disease; vaccines

Funding

  1. Swiss National Science Foundation [CRSII3_147662, 310030_138488, 149511]
  2. Swiss National Science Foundation (SNF) [CRSII3_147662, 310030_138488] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

During evolution, the immune system has diversified to protect the host from the extremely wide array of possible pathogens. Until recently, immune responses were dissected by use of global approaches and bulk tools, averaging responses across samples and potentially missing particular contributions of individual cells. This is a strongly limiting factor, considering that initial immune responses are likely to be triggered by a restricted number of cells at the vanguard of host defenses. The development of novel, single-cell technologies is a major innovation offering great promise for basic and translational immunology with the potential to overcome some of the limitations of traditional research tools, such as polychromatic flow cytometry or microscopy-based methods. At the transcriptional level, much progress has been made in the fields of microfluidics and single-cell RNA sequencing. At the protein level, mass cytometry already allows the analysis of twice as many parameters as flow cytometry. In this review, we explore the basis and outcome of immune-cell diversity, how genetically identical cells become functionally different, and the consequences for the exploration of host-immune defense responses. We will highlight the advantages, trade-offs, and potential pitfalls of emerging, single-cell-based technologies and how they provide unprecedented detail of immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Immunology

Reply to: 'Lack of evidence for intergenerational inheritance of immune resistance to infections'

Natalie Katzmarski, Jorge Dominguez-Andres, Branko Cirovic, Georgios Renieris, Eleonora Ciarlo, Didier Le Roy, Konstantin Lepikhov, Kathrin Kattler, Gilles Gasparoni, Kristian Haendler, Heidi Theis, Marc Beyer, Jos W. M. van der Meer, Leo A. B. Joosten, Jorn Walter, Joachim L. Schultze, Thierry Roger, Evangelos J. Giamarellos-Bourboulis, Andreas Schlitzer, Mihai G. Netea

NATURE IMMUNOLOGY (2022)

Article Biology

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes

Elodie Pronier, Aygun Imanci, Dorothee Selimoglu-Buet, Bouchra Badaoui, Raphael Itzykson, Thierry Roger, Chloe Jego, Audrey Naimo, Maela Francillette, Marie Breckler, Orianne Wagner-Ballon, Maria E. Figueroa, Marine Aglave, Daniel Gautheret, Francoise Porteu, Olivier A. Bernard, William Vainchenker, Francois Delhommeau, Eric Solary, Nathalie M. Droin

Summary: This study demonstrates that TET2 downregulation promotes the production of MIF, a chemokine associated with clonal TET2 downregulation in myeloid cells. Targeting MIF could be a potential therapeutic strategy for conditions associated with TET2 mutations.

COMMUNICATIONS BIOLOGY (2022)

Article Critical Care Medicine

High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure

Irene T. Schrijver, Eleni Karakike, Charlotte Theroude, Petra Baumgartner, Alexandre Harari, Evangelos J. Giamarellos-Bourboulis, Thierry Calandra, Thierry Roger

Summary: This is the first study to associate high levels of M-MDSCs with improved survival in sepsis patients.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2022)

Editorial Material Immunology

COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions

Irene T. Schrijver, Charlotte Theroude, Nikolaos Antonakos, Jean Regina, Didier Le Roy, Pierre-Alexandre Bart, Jean-Daniel Chiche, Matthieu Perreau, Giuseppe Pantaleo, Thierry Calandra, Thierry Roger

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Letter Infectious Diseases

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data

Matteo Bassetti, Valentina Zuccaro, Erika Asperges, Luigia Scudeller, Daniele Roberto Giacobbe

JOURNAL OF INFECTION (2022)

Article Microbiology

Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells

Olivia Munoz, Riddhima Banga, Rachel Schelling, Francesco Andrea Procopio, Andrea Mastrangelo, Pauline Nortier, Khalid Ohmiti, Jean Daraspe, Matthias Cavassini, Craig Fenwick, Laurent Perez, Matthieu Perreau

Summary: This study reveals an immunovirological mechanism by which HIV exploits PD-L1 to suppress Tfh-cell function.

PLOS PATHOGENS (2022)

Article Microbiology

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Craig Fenwick, Priscilla Turelli, Dongchun Ni, Laurent Perez, Kelvin Lau, Cecile Herate, Romain Marlin, Erica Lana, Celine Pellaton, Charlene Raclot, Line Esteves-Leuenberger, Jeremy Campos, Alex Farina, Flurin Fiscalini, Nathalie Dereuddre-Bosquet, Francis Relouzat, Rana Abdelnabi, Caroline S. Foo, Johan Neyts, Pieter Leyssen, Yves Levy, Florence Pojer, Henning Stahlberg, Roger LeGrand, Didier Trono, Giuseppe Pantaleo

Summary: A monoclonal antibody named P2G3 isolated from a previously infected vaccinated donor shows strong neutralizing activity against the SARS-CoV-2 Omicron variant and provides complete prophylactic or therapeutic protection when used alone or in combination with another antibody. The unique epitope of P2G3 may have important implications for combating the Omicron variant.

NATURE MICROBIOLOGY (2022)

Correction Immunology

Transmission of trained immunity and heterologous resistance to infections across generations ( 10.1038/s41590-021-01052-7, 2021)

Natalie Katzmarski, Jorge Dominguez-Andres, Branko Cirovic, Georgios Renieris, Eleonora Ciarlo, Didier Le Roy, Konstantin Lepikhov, Kathrin Kattler, Gilles Gasparoni, Kristian Haendler, Heidi Theis, Marc Beyer, Jos W. M. van der Meer, Leo A. B. Joosten, Joern Walter, Joachim L. Schultze, Thierry Roger, Evangelos J. Giamarellos-Bourboulis, Andreas Schlitzer, Mihai G. Netea

NATURE IMMUNOLOGY (2023)

Article Oncology

Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity

Marc Pfefferle, Irina L. Dubach, Raphael M. Buzzi, Elena Duerst, Nadja Schulthess-Lutz, Livio Baselgia, Kerstin Hansen, Larissa Imhof, Sandra Koernig, Didier Le Roy, Thierry Roger, Rok Humar, Dominik J. Schaer, Florence Vallelian

Summary: The study revealed that CD40 signaling in Clec4f(+) Kupffer cells triggers anti-CD40 antibody-induced liver toxicity. However, controlled erythrophagocytosis and the linked anti-inflammatory signaling by the endogenous metabolite heme can be exploited to reprogram liver macrophages and prevent necroinflammatory liver disease caused by high-dose administration of anti-CD40 antibodies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Clinical Neurology

Ocrelizumab Impairs the Phenotype and Function of Memory CD8(+) T Cells A 1-Year Longitudinal Study in Patients With Multiple Sclerosis

Amandine Mathias, Vasiliki Pantazou, Sylvain Perriot, Mathieu Canales, Samuel Jones, Larise Oberholster, Michael Moulin, Craig Fenwick, Raphael Bernard-Valnet, Marie Theaudin, Caroline Pot, Renaud A. Du Pasquier

Summary: This study aims to investigate the impact of ocrelizumab (OCRE) on immune cell subsets in patients with multiple sclerosis (pwMS). The results showed that OCRE not only depletes B cells, but also reduces memory CD8(+) T cells, which may increase the risk of infections. Therefore, clinicians should pay special attention to the increased infection risk when switching pwMS from other disease-modifying therapies (DMTs) to OCRE.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Immunology

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19

Hakim Hocini, Aurelie Wiedemann, Fabiola Blengio, Cecile Lefebvre, Minerva Cervantes-Gonzalez, Emile Foucat, Pascaline Tisserand, Mathieu Surenaud, Severin Coleon, Melanie Prague, Lydia Guillaumat, Corinne Krief, Craig Fenwick, Cedric Laouenan, Lila Bouadma, Jade Ghosn, Giuseppe Pantaleo, Rodolphe Thiebaut, Yves Levy, Laurent Abel, Amal Abrous, Claire Andrejak, Francois Angoulvant, Delphine Bachelet, Marie Bartoli, Sylvie Behilill, Marine Beluze, Krishna Bhavsar, Anissa Chair, Charlotte Charpentier, Leo Chenard, Catherine Chirouze, Sandrine Couffin-cadiergues, Camille Couffignal, Nathalie D. E. Castro, Marie-Pierre Debray, Dominique Deplanque, Diane Descamps, Alpha Diallo, Fernanda Dias D. A. Silva, Celine Dorival, Xavier Duval, Philippine Eloy, Vincent Enouf, Helene Esperou, Marina Esposito-farese, Manuel Etienne, Aline-Marie Florence, Alexandre Gaymard, Tristan Gigante, Morgane Gilg, Francois Goehringer, Jeremie Guedj, Ikram Houas, Isabelle Hoffmann, Jean-Sebastien Hulot, Salma Jaafoura, Simon Jamard, Ouifiya Kafif, Antoine Khalil, Nadhem Lafhej, Samira Laribi, Minh Le, Quentin LE. Hingrat, Soizic LE. Mestre, Sophie Letrou, Bruno Lina, Guillaume Lingas, Denis Malvy, France Mentre, Hugo Mouquet, Nadege Neant, Christelle Paul, Aurelie Papadopoulos, Ventzislava Petrov-sanchez, Gilles Peytavin, Valentine Piquard, Olivier Picone, Manuel Rosa-calatrava, Benedicte Rossignol, Patrick Rossignol, Carine Roy, Marion Schneider, Coralie Tardivon, Jean-Francois Timsit, Sarah Tubiana, Sylvie Van Der Werf, Benoit Visseaux

Summary: This study investigated the immunological dysfunction underlying the persistence of symptoms in individuals after severe COVID-19 infection. The analysis of cytokines, cell phenotypes, antibodies, and gene expression profiles revealed persistent abnormalities even up to 6 months after hospital discharge, including high levels of activation markers, T-cell abnormalities, decreased antibodies, and upregulation of genes related to blood components. These findings suggest the need for extended clinical follow-up and preventive measures for patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Infectious Diseases

Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients

Benedict Fallet, Mathilde Foglierini, Raphael Porret, Ana Alcaraz-Serna, Christophe Sauvage, Raphael Jenelten, Teofila Caplanusi, Michel Gilliet, Laurent Perez, Craig Fenwick, Raphael Genolet, Alexandre Harari, Sara Bobisse, Raphael Gottardo, Giuseppe Pantaleo, Yannick D. Mueller

Summary: Intradermal skin test (IDT) with mRNA vaccines can be used to measure T cell response in immunocompromised patients who did not generate serological responses after vaccination. The study found that positive IDT reactions in immunocompromised patients were associated with B cell-depleting treatment, while negative reactions were observed in transplant recipients. This study provides a new method to monitor seronegative patients and elderly populations with waning immunity.

JOURNAL OF INFECTION (2023)

Editorial Material Immunology

Editorial: Beneficial and pathological roles of myeloid cells during COVID-19

Lokesh Sharma, Shaon Sengupta, Thierry Roger

FRONTIERS IN IMMUNOLOGY (2023)

Review Microbiology

What Is New in Pulmonary Mucormycosis?

Francois Danion, Anne Coste, Coralie Le Hyaric, Clea Melenotte, Frederic Lamoth, Thierry Calandra, Dea Garcia-Hermoso, Vishukumar Aimanianda, Fanny Lanternier, Olivier Lortholary

Summary: Mucormycosis is a rare and life-threatening fungal infection caused by molds of the order Mucorales. It mainly affects the lungs, following the rhino-orbito-cerebral (ROC) areas and the skin. Risk factors for pulmonary mucormycosis (PM) include hematological malignancies and solid organ transplantation, while ROC infections are commonly associated with diabetes mellitus. The diagnosis of PM relies on CT scans, cultures, PCR tests, and histology, and treatment involves liposomal amphotericin B as the first-line therapy.

JOURNAL OF FUNGI (2023)

Article Infectious Diseases

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys

Craig Fenwick, Priscilla Turelli, Yoan Duhoo, Kelvin Lau, Cecile Herate, Romain Marlin, Myriam Lamrayah, Jeremy Campos, Line Esteves-Leuenberger, Alex Farina, Charlene Raclot, Vanessa Genet, Flurin Fiscalini, Julien Cesborn, Laurent Perez, Nathalie Dereuddre-Bosquet, Vanessa Contreras, Kyllian Lheureux, Francis Relouzat, Rana Abdelnabi, Pieter Leyssen, Yves Levy, Florence Pojer, Roger Le Grand, Didier Trono, Giuseppe Pantaleo

Summary: This study isolated a potent neutralizing antibody that can neutralize various variants of SARS-CoV-2 and potentially provide prophylactic protection for immunocompromised patients.

JOURNAL OF INFECTION (2023)

No Data Available